Bioequivalence and Bioavailability Forum 01:03 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

posted by jag009 - NJ, 2018-04-13 21:23  - Posting: # 18680
Views: 964

Hi,

» Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT

I did a bunch of them a few years back but ours were NDAs (505b2s, ODTs vs reg tablets). Tablet on tongue, subject can't chew but can "suck" (you know, the small movement of your tongue like when you swallow something) on the tablet. After 10 or 30 seconds (don't remember details) check mouth. Once everything is disappear, then we give water...

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,037 posts in 4,061 threads, 1,300 registered users;
online 13 (2 registered, 11 guests [including 10 identified bots]).

An expert is a man who has made all the mistakes,
which can be made, in a very narrow field.    Niels Bohr

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed